Supplement Article

DELETE Understanding the Lifetime Course of Schizophrenia

Social Cognition in Schizophrenia

June 5, 2014

DELETE Understanding the Lifetime Course of Schizophrenia

Why Are the Outcomes in Patients With Schizophrenia So Poor?

June 5, 2014

Supplement Article

Negative Symptoms of Schizophrenia

February 21, 2014

Read about the negative symptoms of schizophrenia and why clinicians should differentiate between primary and secondary symptoms to select the best treatment.

Supplement Article

Disability in Schizophrenia: Contributing Factors and Validated Assessments

February 21, 2014

Supplement Article

Measurements of Response, Remission, and Recovery in Schizophrenia and Examples for Their Clinical Application

February 21, 2014

Supplement Article

Unmet Needs in the Treatment of Schizophrenia: New Targets to Help Different Symptom Domains

February 21, 2014

DELETE Managing the Full Range of Symptoms to Achieve Lasting Remission

The Multifactorial Presentation of Depression in Acute Care

October 29, 2013

DELETE Managing the Full Range of Symptoms to Achieve Lasting Remission

Neurotransmitter Targeting in the Treatment of Depression

October 29, 2013

DELETE Managing the Full Range of Symptoms to Achieve Lasting Remission

Residual Symptoms and Relapse: Mood, Cognitive Symptoms, and Sleep Disturbances

October 29, 2013

DELETE Managing the Full Range of Symptoms to Achieve Lasting Remission

Using Measurement Strategies to Identify and Monitor Residual Symptoms

October 29, 2013

Supplement Article

Orexin and the Sleep-Wake Cycle

September 15, 2013

What is the sleep-wake cycle? Read a case explaining the roles of sleep and the orexin system and how that relates to insomnia.

Supplement Article

MAO Inhibitors for Treating Depression

July 27, 2012

Understand why Monoamine oxidase inhibitors (MAOIs) are effective treatments but underused due to potential dietary and drug interactions.

Supplement Article

Discussion: A Fresh Look at Monoamine Oxidase Inhibitors for Depression

July 27, 2012

Supplement Article

The Epidemiology of Depression and the Evolution of Treatment

July 27, 2012

Supplement Article

Introduction: A Fresh Look at Monoamine Oxidase Inhibitors for Depression

July 27, 2012

Supplement Article

Issues in Adherence to Treatment With Monoamine Oxidase Inhibitors and the Rate of Treatment Failure

July 27, 2012

Supplement Article

The Use of Monoamine Oxidase Inhibitors in Primary Care

July 27, 2012

Supplement Article

The Role of Monoamine Oxidase Inhibitors in Depression Treatment Guidelines

July 27, 2012

Supplement Article

What Are Monamine Oxidase Inhibitors?

July 27, 2012

Read an article on why Monamine Oxidase Inhibitors (MAOIs) have been replaced by newer and safer antidepressants.

DELETE Beyond Selective Serotonin Reuptake Inhibitors

Relationship of Neurotransmitters to the Symptoms of Major Depressive Disorder

April 30, 2008

DELETE Beyond Selective Serotonin Reuptake Inhibitors

Strategies for Switching Antidepressants to Achieve Maximum Efficacy

April 30, 2008

DELETE Beyond Selective Serotonin Reuptake Inhibitors

Tolerability of Modern Antidepressants

April 30, 2008

Supplement Article

Antipsychotic Medication in the Elderly

January 1, 2004

Rate the appropriateness of using an antipsychotic to treat each of the following conditions in an older patient.

Supplement Article

Guideline 16: Combining Medications in Older Patients

January 1, 2004